| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.0022 | 0.9 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.0022 | 0.9 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | -0.012 | 0.9 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0022 | 0.9 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |